BREAKING
NEW
20:45
OpenAI Breach Hardens White House AI Security Doctrine
20:25
Michigan Primary Tests Democrats' Left-Center Fault Line
20:05
MS Drug's U.S. Path Tests Medicare's Coverage Speed
09:45
AI Cost Controls Elude Buyers as Pricing Models Shift
09:25
State Tariff Suits Expose Forced Labor Law's Gray Zones
09:05
State Tariff Suits Put Trump's Trade War Legal Limits in Focus
20:45
Xbox Price Surge Tests U.S. Console Market Resilience
20:25
Cyclospora Surge Puts CDC Summer Travel Alerts Under Scrutiny
20:05
Williams Sisters' Cincinnati Doubles Run Tests Comeback Math
09:45
US-Japan Yen Pact Reshapes Dollar Diplomacy Stakes
US Politics
Economy
Finance
Sports
Entertainment
Society
Health
Auto
Digital
World
World Cup 2026
Tools
CITIES
New York
Los Angeles
Chicago
Houston
Miami
Washington
San Francisco
Seattle
News
Zen
News
SECTIONS
US Politics
133 Articles
Senate & Congress
Democrats
Republicans
White House
World
168 Articles
Ukraine War
Middle East
NATO
China
UN & Diplomacy
Economy
76 Articles
Markets
Trade
Housing
Inflation
Tech
92 Articles
AI
Big Tech
Cybersecurity
Social Media
Electric Vehicles
Society
99 Articles
Immigration
Education
Crime
Environment
Cost of Living
Health
36 Articles
NHS
Mental Health
Vaccines
Nutrition
Sports
147 Articles
Premier League
Champions League
F1
Cricket
Tennis
Climate
96 Articles
Net Zero
Renewable Energy
Extreme Weather
⭐ Daily Horoscope
Contact the Newsroom
Results for “Drug'S”
5 results
Search
All
5
Health
3
Economy
1
World
1
Health
Just now
MS
Drug's
U.S. Path Tests Medicare's Coverage Speed
Fampridine's NHS approval renews pressure on CMS to act on nerve-signal therapies
Health
08 Jun 2026
Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate
A new pancreatic cancer pill, Daraxonrasib, is reshaping U.S. oncology spending debates, offering a targeted therapy and challeng…
World
16 May 2026
United Kingdom Cannabis Laws: A Complete Breakdown
Explore the complex cannabis laws in the United Kingdom, examining the ongoing criminalization, regional enforcement variations, …
Health
24 Jun 2026
Type 1 Diabetes Drug Delay Puts U.S. Insurers on Defense
European immunotherapy approvals for Type 1 diabetes are prompting U.S. insurers to reassess coverage of preventative treatments …
Economy
08 Jul 2026
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
GLP-1 drug surge quietly disrupts retail, food, and beverage sectors
Topics:
NHS Policy
Ukraine War
NHS
Net Zero
Starmer
Zero
League
Artificial Intelligence
Ukraine
Senate
Russia
Champions
Champions League
Mental
Health
Renewable Energy
Final
Bill
Grid
Block
Target
Energy
Security
Council
Home
Search
Live
Sections
More